SonoVascular develops the SonoThrombectomy System, which is designed for the interventional treatment of venous thromboembolism (VTE). This system focuses on improving outcomes in thrombus removal using a specialized catheter.

SonoVascular

MedTech World is a global event management company that organizes an annual investor and entrepreneur conference in the medtech and health tech sector in Malta, along with multiple roadshow events worldwide. It fosters collaboration among stakeholders to enhance healthcare.

MedTech World

SonoVascular, Inc. | 919 followers on LinkedIn. Therapeutic Ultrasound-Based Solutions for Vascular Care | SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system, SonoThrombectomy™, that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to remove blood clots more effectively. The system uniquely combines:
(i) ultrasound, (ii) microbubbles, (iii) low dose thrombolytic drug, and (iv) mechanical retrieval and aspiration, delivered via an integrated intravascular catheter system.

SonoVascular’s technology has been engineered to address and overcome the deficiencies and limitations of current interventional devices.

VP of Engineering at SonoVascular

Jacob Ruprecht

Engineer, Catheters and Accessories - SonoVascular Inc

Hannah Florez

Lucas Fellow at the University of North Carolina at Chapel Hill | Biomedical Engineering

Daniel Menichella

SonoVascular, Inc.

Thank you to #NCBiotech for hosting a successful Triangle Venture Day! We appreciated the opportunity to have Jacob Ruprecht share our exciting progress with investors and strategic partners and further connect with the medtech ecosystem in the RTP community. #medtech #innovation #medtechstartups #Partnership #MedicalTechnology #thrombectomy #VTE

SonoVascular, Inc. has announced the successful initiation of its first-in-human study of the company’s SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilises multiple mechanisms of action to treat patients with venous thromboembolism ( #VTE ). The catheter-based system combines microbubble-mediated cavitation with low-dose thrombolytic delivery to treat clots with no blood loss. Read more: https://lnkd.in/ebCMhM28

Venous News

SonoVascular, Inc. has announced the successful initiation of its first-in-human study (FIH) of the company’s SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilises multiple mechanisms of action to treat patients with venous thromboembolism ( #VTE ). Albrecht Krämer Hospital Dipreca https://t.ly/kJwCd

Interventional News

SonoVascular is excited to announce that our First-In-Human case with the SonoThrombectomy System was successfully completed by Dr. Manuel Espíndola, Dr. Albrecht Krämer and their clinical team at Hospital DIPRECA in Santiago, Chile, supported on-site by SonoVascular personnel and Bioscience staff (CRO). This major milestone is the first step in our mission to transform the treatment of venous thromboembolism. We wish to take a moment to thank all of our partners, without whom we could not have accomplished this pivotal achievement. We look forward to continuing to work with our extended team on our high-priority and focused journey. Read our full press release here: https://lnkd.in/eqvu-8nd #medtech #innovation #medtechstartups #medtechinnovator #MedicalTechnology #thrombectomy #VTE

We are grateful to have such a strong partner in the NCBiotech Center – thank you for your support! #medtech #medtechstartups #Partnership #DVT

We are thrilled to announce a strategic collaboration with Lantheus to use DEFINITY microbubbles in combination with SonoVascular's SonoThrombectomy System to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). Lantheus is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents, and DEFINITY is the leading ultrasound enhancing agent in the U.S. Since its launch in 2001, DEFINITY has been used in over 25 million imaging procedures throughout the world. This collaboration presents an extraordinary opportunity to leverage Lantheus' proven microbubble solutions with our innovative SonoThrombectomy System, aiming to significantly enhance treatment outcomes for DVT and PE patients. We invite you to be a part of the journey with SonoVascular! #medtech #innovation #healthtech #medtechstartups #medtechinnovator #Partnership #MedicalTechnology #DVT #PulmonaryEmbolism https://lnkd.in/eaeHHrZE

Want to learn more about our novel pharmaco-mechanical thrombectomy approach? Check out Venous News’ writeup of Dr. Marston presenting preclinical results of our venous thrombectomy solution during the 2024 American Venous Forum held earlier this year. Our team looks forward to partnering with world class physicians such as Dr. Marston to bring this therapy into the clinic. Thank you to Venous News for the profile! #medtech #innovation #healthtech #medtechstartups #medtechinnovator https://lnkd.in/g5PyCcNj

Clot chronicity, that is, how the consistency of the clot changes as it ages, from a soft red blood cell-rich gob to a tough mass made of fibrin and collagen that adheres tightly to the vessel wall (the clot continuum is clinically categorized as acute, subacute, and chronic), would dictate a variety of removal strategies. Today, there are several on-label drug and thrombectomy strategies (see Figure 3). Devices for deep venous disease are having their day; the markets are becoming crowded. Second-generation movers must now find meaningful ways to differentiate themselves. MedTech Strategist interviews two companies with outside-the-box solutions: SonoVascular, Inc. , in venous thrombectomy, and Auxetics , the developer of a novel venous stent. Part 2 of a 2-part review of the deep venous device market: https://bit.ly/3Vqn7XM #medtech #thrombectomy #deepvenous #venous

Metric
Company Name	SonoVascular	MedTech World
Symbol
MSH ID	COM:SONOVASCULAR	WORLD:MED-TECH
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Commercial & Professional Services
Industry	Medical Devices	Event Management
Country	US	MT
Stage
Employee Count
Website	sonovascular.com	med-tech.world
LinkedIn	sonovascular.com	mtw-medtech-world
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SONO

COM:SONOVASCULAR

SonoVascular

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue